Page last updated: 2024-10-31

nadolol and Leukemia

nadolol has been researched along with Leukemia in 1 studies

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yuan, Y1
Du, L1
Tan, R1
Yu, Y1
Jiang, J1
Yao, A1
Luo, J1
Tang, R1
Xiao, Y1
Sun, H1

Other Studies

1 other study available for nadolol and Leukemia

ArticleYear
Design, Synthesis, and Biological Evaluations of DOT1L Peptide Mimetics Targeting the Protein-Protein Interactions between DOT1L and MLL-AF9/MLL-ENL.
    Journal of medicinal chemistry, 2022, 06-09, Volume: 65, Issue:11

    Topics: Histone-Lysine N-Methyltransferase; Humans; Leukemia; Methyltransferases; Myeloid-Lymphoid Leukemia

2022